Table of Contents

January 1, 2025; Volume 66,Issue 1

  1. Galassi, Anthony

    1. [<sup>11</sup>C]PS13 Demonstrates Pharmacologically Selective and Substantial Binding to Cyclooxygenase-1 in the Human Brain
      [11C]PS13 Demonstrates Pharmacologically Selective and Substantial Binding to Cyclooxygenase-1 in the Human Brain
      Nafiseh Ghazanfari, Jeih-San Liow, Min-Jeong Kim, Raven Cureton, Adrian Lee, Carson Knoer, Madeline Jenkins, Jinsoo Hong, Jose A. Montero Santamaria, H. Umesha Shetty, Anthony Galassi, Paul Wighton, Martin Nørgaard, Douglas N. Greve, Sami S. Zoghbi, Victor W. Pike, Robert B. Innis and Paolo Zanotti-Fregonara
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 117-122; DOI: https://doi.org/10.2967/jnumed.124.267928

  2. Galldiks, Norbert

    1. Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands
      Nathalie L. Albert, Matthias Preusser, Norbert Galldiks and Jana Ivanidze
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 24-25; DOI: https://doi.org/10.2967/jnumed.124.268314

  3. Garibotto, Valentina

    1. Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
      Open Access
      Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
      Lyduine E. Collij, Gérard N. Bischof, Daniele Altomare, Ilse Bader, Mark Battle, David Vállez García, Isadora Lopes Alves, Robin Wolz, Rossella Gismondi, Andrew Stephens, Zuzana Walker, Philip Scheltens, Agneta Nordberg, Juan Domingo Gispert, Alexander Drzezga, Andrés Perissinotti, Silvia Morbelli, Christopher Buckley, Valentina Garibotto, Giovanni B. Frisoni, Gill Farrar and Frederik Barkhof; on behalf of the AMYPAD Consortium
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 110-116; DOI: https://doi.org/10.2967/jnumed.124.268119

  4. Gauthier, Serge

    1. Comparison Between Brain and Cerebellar Autoradiography Using [<sup>18</sup>F]Flortaucipir, [<sup>18</sup>F]MK6240, and [<sup>18</sup>F]PI2620 in Postmortem Human Brain Tissue
      Comparison Between Brain and Cerebellar Autoradiography Using [18F]Flortaucipir, [18F]MK6240, and [18F]PI2620 in Postmortem Human Brain Tissue
      Antonio Aliaga, Joseph Therriault, Kely Monica Quispialaya, Arturo Aliaga, Robert Hopewell, Nesrine Rahmouni, Arthur C. Macedo, Peter Kunach, Jean-Paul Soucy, Gassan Massarweh, Aida Abreu Diaz, Tharick A. Pascoal, Andreia Rocha, Marie-Christine Guiot, Luiza S. Machado, Marco Antônio De Bastiani, Débora Guerini de Souza, Diogo O. Souza, Serge Gauthier, Eduardo R. Zimmer and Pedro Rosa-Neto
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 123-129; DOI: https://doi.org/10.2967/jnumed.124.267539

  5. Ge, Luna

    1. Preclinical Evaluation and Pilot Clinical Study of CD137 PET Radiotracer for Noninvasive Monitoring Early Responses of Immunotherapy
      Preclinical Evaluation and Pilot Clinical Study of CD137 PET Radiotracer for Noninvasive Monitoring Early Responses of Immunotherapy
      Kai Cheng, Luna Ge, Miaomiao Song, Wanhu Li, Jinsong Zheng, Jingru Liu, Yuxi Luo, Pengfei Sun, Shengnan Xu, Zhen Cheng, Jinming Yu and Jie Liu
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 40-46; DOI: https://doi.org/10.2967/jnumed.124.268068

  6. Ghazanfari, Nafiseh

    1. [<sup>11</sup>C]PS13 Demonstrates Pharmacologically Selective and Substantial Binding to Cyclooxygenase-1 in the Human Brain
      [11C]PS13 Demonstrates Pharmacologically Selective and Substantial Binding to Cyclooxygenase-1 in the Human Brain
      Nafiseh Ghazanfari, Jeih-San Liow, Min-Jeong Kim, Raven Cureton, Adrian Lee, Carson Knoer, Madeline Jenkins, Jinsoo Hong, Jose A. Montero Santamaria, H. Umesha Shetty, Anthony Galassi, Paul Wighton, Martin Nørgaard, Douglas N. Greve, Sami S. Zoghbi, Victor W. Pike, Robert B. Innis and Paolo Zanotti-Fregonara
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 117-122; DOI: https://doi.org/10.2967/jnumed.124.267928

  7. Ghodsi, Alireza

    1. PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received <sup>177</sup>Lu-PSMA-617: Importance of <sup>18</sup>F-FDG–Avid Discordant Findings
      PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177Lu-PSMA-617: Importance of 18F-FDG–Avid Discordant Findings
      Ridvan Arda Demirci, Alireza Ghodsi, Roman Gulati, Sanaz Behnia, Peter S. Nelson, Heather H. Cheng, Todd A. Yezefski, Michael C. Haffner, Jessica E. Hawley, Robert B. Montgomery, Evan Y. Yu, Michael T. Schweizer, Delphine L. Chen and Amir Iravani
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 47-53; DOI: https://doi.org/10.2967/jnumed.124.268167

  8. Gismondi, Rossella

    1. Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
      Open Access
      Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
      Lyduine E. Collij, Gérard N. Bischof, Daniele Altomare, Ilse Bader, Mark Battle, David Vállez García, Isadora Lopes Alves, Robin Wolz, Rossella Gismondi, Andrew Stephens, Zuzana Walker, Philip Scheltens, Agneta Nordberg, Juan Domingo Gispert, Alexander Drzezga, Andrés Perissinotti, Silvia Morbelli, Christopher Buckley, Valentina Garibotto, Giovanni B. Frisoni, Gill Farrar and Frederik Barkhof; on behalf of the AMYPAD Consortium
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 110-116; DOI: https://doi.org/10.2967/jnumed.124.268119

  9. Gispert, Juan Domingo

    1. Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
      Open Access
      Quantification Supports Amyloid PET Visual Assessment of Challenging Cases: Results from the AMYPAD Diagnostic and Patient Management Study
      Lyduine E. Collij, Gérard N. Bischof, Daniele Altomare, Ilse Bader, Mark Battle, David Vállez García, Isadora Lopes Alves, Robin Wolz, Rossella Gismondi, Andrew Stephens, Zuzana Walker, Philip Scheltens, Agneta Nordberg, Juan Domingo Gispert, Alexander Drzezga, Andrés Perissinotti, Silvia Morbelli, Christopher Buckley, Valentina Garibotto, Giovanni B. Frisoni, Gill Farrar and Frederik Barkhof; on behalf of the AMYPAD Consortium
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 110-116; DOI: https://doi.org/10.2967/jnumed.124.268119

  10. Gitto, Sarah B.

    1. [<sup>18</sup>F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [<sup>18</sup>F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status
      [18F]Fluorthanatrace PET in Ovarian Cancer: Comparison with [18F]FDG PET, Lesion Location, Tumor Grade, and Breast Cancer Gene Mutation Status
      Joanna K. Weeks, Austin R. Pantel, Sarah B. Gitto, Fang Liu, Erin K. Schubert, Daniel A. Pryma, Michael D. Farwell, David A. Mankoff, Robert H. Mach, Fiona Simpkins and Lilie L. Lin
      Journal of Nuclear Medicine January 1, 2025, 66 (1) 34-39; DOI: https://doi.org/10.2967/jnumed.124.267627
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue